JP2025501611A5 - - Google Patents
Info
- Publication number
- JP2025501611A5 JP2025501611A5 JP2024538275A JP2024538275A JP2025501611A5 JP 2025501611 A5 JP2025501611 A5 JP 2025501611A5 JP 2024538275 A JP2024538275 A JP 2024538275A JP 2024538275 A JP2024538275 A JP 2024538275A JP 2025501611 A5 JP2025501611 A5 JP 2025501611A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- amino acid
- domain
- seq
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292125P | 2021-12-21 | 2021-12-21 | |
| US63/292,125 | 2021-12-21 | ||
| US202263363918P | 2022-04-29 | 2022-04-29 | |
| US63/363,918 | 2022-04-29 | ||
| US202263364285P | 2022-05-06 | 2022-05-06 | |
| US63/364,285 | 2022-05-06 | ||
| US202263378928P | 2022-10-10 | 2022-10-10 | |
| US63/378,928 | 2022-10-10 | ||
| US202263384830P | 2022-11-23 | 2022-11-23 | |
| US63/384,830 | 2022-11-23 | ||
| PCT/US2022/081929 WO2023122532A2 (en) | 2021-12-21 | 2022-12-19 | Compositions and methods for engineering treg cells for treatment of diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501611A JP2025501611A (ja) | 2025-01-22 |
| JP2025501611A5 true JP2025501611A5 (https=) | 2025-11-25 |
Family
ID=86903699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538275A Pending JP2025501611A (ja) | 2021-12-21 | 2022-12-19 | 糖尿病治療用Ｔｒｅｇ細胞を組換えるための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250213686A1 (https=) |
| EP (1) | EP4452286A4 (https=) |
| JP (1) | JP2025501611A (https=) |
| AU (1) | AU2022420487A1 (https=) |
| CA (1) | CA3242057A1 (https=) |
| IL (1) | IL313581A (https=) |
| WO (1) | WO2023122532A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025255344A1 (en) * | 2024-06-05 | 2025-12-11 | Benaroya Research Institute At Virginia Mason | Compositions and methods for engineering tregs for treatment of diabetes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009061442A1 (en) * | 2007-11-06 | 2009-05-14 | Children's Medical Center Corporation | Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells |
| WO2020264039A1 (en) * | 2019-06-27 | 2020-12-30 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Artificial antigen-specific immunoregulatory t (airt) cells |
| EP4267171A4 (en) * | 2020-12-22 | 2025-05-21 | Seattle Children's Hospital (DBA Seattle Children's Research Institute) | Antigen-specific immunoregulatory artificial T cells (AIRT) |
-
2022
- 2022-12-19 IL IL313581A patent/IL313581A/en unknown
- 2022-12-19 US US18/719,083 patent/US20250213686A1/en active Pending
- 2022-12-19 CA CA3242057A patent/CA3242057A1/en active Pending
- 2022-12-19 JP JP2024538275A patent/JP2025501611A/ja active Pending
- 2022-12-19 WO PCT/US2022/081929 patent/WO2023122532A2/en not_active Ceased
- 2022-12-19 AU AU2022420487A patent/AU2022420487A1/en active Pending
- 2022-12-19 EP EP22912622.2A patent/EP4452286A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102873899B1 (ko) | 인터루킨-2 변이체 및 이의 사용 방법 | |
| TWI710572B (zh) | 改善配對的ｔ細胞受體 | |
| AU2017373815C1 (en) | Novel T cell receptors and immune therapy using the same | |
| ES2877129T3 (es) | Sistema de señalización de receptor de antígeno quimérico (CAR) | |
| CN110818802B (zh) | 一种嵌合t细胞受体star及其应用 | |
| Haga-Friedman et al. | Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity | |
| EP2585098B1 (en) | Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules for use in treating obesity and obesity-related disorders | |
| WO2020252421A2 (en) | Novel interleukin-2 variants and bifunctional fusion molecules thereof | |
| CN105017429A (zh) | 多聚体il-15可溶性融合分子与其制造与使用方法 | |
| KR20220110233A (ko) | 펩티드-mhc ii 단백질 작제물 및 그의 용도 | |
| JPH09509944A (ja) | Ｔ細胞調節のための製品と方法 | |
| EP2184297A1 (en) | HLA-G polypeptides and pharmaceutical uses thereof | |
| Romano et al. | Molecular cloning and characterization of CD4 in an aquatic mammal, the white whale Delphinapterus leucas | |
| EP3844175A1 (en) | Combination therapies comprising pd-1-based chimeric proteins | |
| JP2010509181A (ja) | 融合ポリペプチドを細胞へ輸送する方法 | |
| US20220305117A1 (en) | Combination of hepatitis b virus (hbv) vaccines and hbv-targeting rnai | |
| JP2025501611A5 (https=) | ||
| JP2024500917A5 (https=) | ||
| CN106459175A (zh) | 结合至源自人前胰岛素原(ppi)蛋白的alwgpdpaaa的t细胞受体 | |
| CN101688210B (zh) | 促红细胞生成素融合蛋白 | |
| CN115151272B (zh) | 嵌合抗原受体的优化 | |
| KR100719020B1 (ko) | 재조합 아세틸콜린 수용체 폴리펩티드, 폴리펩티드 유도체및 이를 유효성분으로 포함하는 중증근무력증 치료제 | |
| US12115190B2 (en) | IRF-4 engineered T cells and uses thereof in treating cancer | |
| WO2026025111A1 (en) | Nucleic acids and pharmaceutical compositions for immune cell engagers | |
| IL304916A (en) | Il-15 fusion proteins and methods of making and using same |